ACHV Latest Headlines

Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers

at seekingalpha.com (Thu, 15-Jan 7:10 AM)

ACHV Names Erik Atkisson Chief Legal Officer Amid Critical FDA Review for Cytisinicline

Market Chameleon (Tue, 21-Oct 10:31 AM)

FDA Grants National Priority Voucher to Achieve Life Sciences: Cytisinicline Could Revolutionize Vaping Cessation

Market Chameleon (Mon, 20-Oct 10:34 AM)

ACHV Gains FDA National Priority Voucher—Expedited Pathway for First-in-Class Vaping Cessation Therapy

Market Chameleon (Fri, 17-Oct 10:31 AM)

FDA National Priority Voucher Fast-Tracks Cytisinicline: What Achieve Life Sciences' Breakthrough Means for Vaping Cessation

Market Chameleon (Fri, 17-Oct 9:41 AM)